Dr. Arend on the Rationale of Novel Combinations in Gynecologic Cancer
February 10th 2018Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer Center, discusses the rationale behind novel combination strategies for patients with gynecologic cancer.
Dr. Moore on Immunotherapy and PARP Combinations in BRCA-Mutated Ovarian Cancer
February 10th 2018Kathleen N. Moore, MD, assistant professor, The Stephenson Cancer Center, The University of Oklahoma, discusses combinations of immunotherapy with PARP inhibitors for patients with BRCA-mutated ovarian cancer.
Robotic Radiosurgery May Provide New Option for Recurrent Gynecologic Cancers
The administration of stereotactic body radiation therapy through the use of CyberKnife therapy appears to be a safe and effective salvage treatment for women with previously irradiated, locally recurrent gynecologic cancer.
Study Highlights Impact of Race, Geography on Genetic Variation in Endometrial Cancer
An analysis of black women of Caribbean descent with type I or type II endometrial cancer showed that this population expressed significant differences in genetic variations compared with a nationwide population of patients with endometrial cancer.
Dr. Al-Niaimi on the Future Role of Cytoreductive Surgery in Ovarian Cancer
February 9th 2018Ahmed N. Al-Niaimi, MD, assistant professor of obstetrics and gynecology, University of Wisconsin School of Medicine and Public Health, discusses the future role for cytoreductive surgery for the treatment of patients with ovarian cancer.